<DOC>
	<DOCNO>NCT01812447</DOCNO>
	<brief_summary>EMPROVE multicenter , prospective , randomize , control study design evaluate safety long-term effectiveness Spiration Valve System patient emphysema . Patients appropriate EMPROVE study currently medical treatment still symptomatic . EMPROVE also accept α-1 antitrypsin deficiency patient .</brief_summary>
	<brief_title>Evaluation Spiration® Valve System Emphysema Improve Lung Function</brief_title>
	<detailed_description>The Spiration Valve small , one-way valve use block air enter diseased portion lung . This help reduce volume diseased lung due hyperinflation . Volume reduction diseased lung show improve lung function quality life measure people live emphysema . The Spiration Valve place diseased section lung use tool call bronchoscope . A bronchoscope small tube camera end . The bronchoscope enters lung mouth . The Spiration Valve deliver place target airway via another thin tube call catheter travel bronchoscope . - Once place , Spiration Valve expand contract breathe , create complete seal around airway - The seal block air enter target lobe time allow trap air fluid escape . - This cause diseased ( hyper-inflated ) lung reduce volume collapse - Studies show volume reduction may allow healthy lung function well - More information description Spiration Valve System find EMPROVE clinical trial website , www.EmphysemaTrial.com Safety outcomes Spiration Valve System emphysema publish several peer-reviewed journal . The article list represent summary exist literature regard use Spiration Valve System treatment emphysema . The selected article provide help understand body data describe use Spiration Valve System . 1 . Unilateral Versus Bilateral Endoscopic Lung Volume Reduction : A Comparative Case Study , NCT00995852 Eberhardt R , Gompelmann D , Schuhmann M , Heussel CP , Herth FJ . Complete unilateral v partial bilateral endoscopic lung volume reduction patient bilateral lung emphysema . Chest . 2012 Oct ; 142 ( 4 ) :900-908 2 . Clinical Trial Evaluate Safety Effectiveness IBV® Valve System Treatment Severe Emphysema ( IBV®Valve ) , NCT00475007 Wood DE , Nader DA , Springmeyer SC , Elstad MR , Coxson HO , Chan A , Rai NS , Mularski RA , Cooper CB , Wise RA , Jones PW , Mehta AC , Gonzalez X , Sterman DH ; IBV Valve Trial Research Team . The IBV Valve trial : multicenter , randomize , double-blind trial endobronchial therapy severe emphysema . J Bronchology Interv Pulmonol . 2014 Oct ; 21 ( 4 ) :288-297 3 . European Multi-Center Post Market Study IBV Valve System , NCT00880724 Ninane V , Geltner C , Bezzi M , Foccoli P , Gottlieb J , Welte T , Seijo L , Zulueta JJ , Munavvar M , Rosell A , Lopez M , Jones PW , Coxson HO , Springmeyer SC , Gonzalez X. Multicentre European study treatment advance emphysema bronchial valve . Eur Respir J . 2012 Jun ; 39 ( 6 ) :1319-1325</detailed_description>
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pulmonary Emphysema</mesh_term>
	<criteria>Subject severe heterogeneous emphysema severe dyspnea Subject certify meet criterion ATS/ERS guideline management stable COPD Subject must able demonstrate physical ability participate study perform 6minute walk distance ≥ 140 Subject abstain cigarette smoke 4 month willing abstain throughout study Pulmonary Function Testing Results ( PFT 's ) demonstrate : FEV1 ≤ 45 % predict RV ≥ 150 % predict TLC ≥ 100 % predict Patient BMI &lt; 15 kg/m2 Arterial Blood Gas Level ( ABG ) indicate : PCO2 &gt; 55 mm Hg PO2 &lt; 45 mm Hg room air Subject diffuse emphysema pattern Subject bronchitis sputum production &gt; 4 Tablespoons 60 ml per day Subject active asthma ( &gt; 15 mg prednisone daily ) Giant bulla ( &gt; 1/3 volume lung ) Pulmonary hypertension Subject prior major lung surgery recent hospitalization COPD exacerbation respiratory infection</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Endobronchial Valves</keyword>
	<keyword>Intrabronchial Valves</keyword>
	<keyword>Bronchial Valve</keyword>
	<keyword>Chronic Obstructive Pulmonary Disease</keyword>
	<keyword>COPD</keyword>
	<keyword>Pulmonary Disease , Chronic Obstructive</keyword>
	<keyword>Bronchoscopic Lung Volume Reduction</keyword>
	<keyword>BLVR</keyword>
	<keyword>TLVR</keyword>
	<keyword>Emphysema</keyword>
	<keyword>Pulmonary Emphysema</keyword>
	<keyword>Pathologic Process</keyword>
	<keyword>Lung Diseases</keyword>
	<keyword>Respiratory Tract Disease</keyword>
</DOC>